Question 1: A facility QC technologist may begin using the ACR Digital Mammography QC Manual on a mammography unit __________. |
Reference: | Berns EA, Pfieffer DE, Adent C, et al. Digital Mammography Quality Control Manual. Reston, Va: American College of Radiology; 2018, p15. |
Choice A: | As soon as they have received their ACR DM Phantom |
Choice B: | Once the medical physicist has conducted an annual survey of the digital mammography unit using the ACR DM QC manual and phantom |
Choice C: | Once their facility has undergone its next scheduled MQSA inspection under the manufacturer’s QC manual |
Choice D: | Once they have notified the ACR that they intend to transition QC manuals |
Question 2: Once a mammography unit has had its transition survey for the ACR Digital Mammography QC manual, all affiliated display devices (on and off-site) must have their transitions completed ________. |
Reference: | The American College of Radiology Digital Mammography QC Manual: Frequently Asked Questions (revised 10/03/2019), p5. https://www.acraccreditation.org/-/media/ACRAccreditation/Documents/Resources/DMQC/DMQCFAQs.pdf?la=en |
Choice A: | Within 1 month |
Choice B: | Within 3 months |
Choice C: | Within 6 months |
Choice D: | Before the next regularly scheduled annual survey for that mammography unit |
Choice E: | The display devices are not required to transition to the ACR QC manual |
Question 3: When the technologist is performing the Phantom Image Quality test under the ACR Digital Mammography QC manual, what technique should be used to acquire the phantom image? |
Reference: | Berns EA, Pfieffer DE, Adent C, et al. Digital Mammography Quality Control Manual. Reston, Va: American College of Radiology; 2018, p39. |
Choice A: | The technical factors provided in the manufacturer’s QC manual |
Choice B: | A photo-timed exposure at the maximum kVp |
Choice C: | The technique for a 4.2 cm thick compressed breast consisting of 50% glandular and 50% adipose tissue as used clinically during routine screening mammography exams |
Choice D: | A manual technique specified by the physicist |
Question 4: If the LIP is not available on the day of the MQSA inspection, what are the site's options to demonstrate compliance with LIP QC/QA oversight (EQUIP question #3)? |
Reference: | MQSA EQUIP attestation, found at: https://www.fda.gov/media/101655/download |
Choice A: | There are no options, you cannot complete the inspection without the LIP. |
Choice B: | The LIP may seek out, sign, and date, an FDA provided attestation form to serve as their communications. |
Choice C: | The facility may offer the inspector an LIP signed written policy containing all required elements. |
Choice D: | Both B and C |
Question 5: In a multi-site network of certified facilities, where the IP and RT move between multiple sites, will a single clinical image quality review (CIQR) assessment per IP and RT from just one site suffice? |
Reference: | MQSA EQUIP FAQ, found at (p.5): https://www.fda.gov/media/101293/download |
Choice A: | No, because MQSA regulates facilities, not people. |
Choice B: | No, because we may have missed an IP/RT combination. |
Choice C: | Yes, because we have assessed each IP and RT. |
Choice D: | Yes, because we have assessed a large sample size. |
Question 6: Who can complete the periodic clinical image quality review (CIQR) for a site? |
Reference: | MQSA EQUIP FAQ, found at (page 6): https://www.fda.gov/media/101293/download |
Choice A: | The lead QC technologist |
Choice B: | The mammography manager |
Choice C: | The qualified medical physicist |
Choice D: | Any of the above, so long as they are working in conjunction with an IP |